EUROFINS SCIENTIFIC (ESF0.DE) Fundamental Analysis & Valuation

FRA:ESF0 • FR0014000MR3

Current stock price

61.7 EUR
+0.6 (+0.98%)
Last:

This ESF0.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ESF0.DE Profitability Analysis

1.1 Basic Checks

  • ESF0 had positive earnings in the past year.
  • In the past year ESF0 had a positive cash flow from operations.
  • Each year in the past 5 years ESF0 has been profitable.
  • Each year in the past 5 years ESF0 had a positive operating cash flow.
ESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • ESF0 has a Return On Assets (3.73%) which is in line with its industry peers.
  • With a decent Return On Equity value of 9.02%, ESF0 is doing good in the industry, outperforming 61.11% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 6.74%, ESF0 is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ESF0 is below the industry average of 9.09%.
  • The last Return On Invested Capital (6.74%) for ESF0 is above the 3 year average (6.44%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROIC 6.74%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
ESF0.DE Yearly ROA, ROE, ROICESF0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ESF0 has a Profit Margin (5.62%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of ESF0 has declined.
  • Looking at the Operating Margin, with a value of 10.87%, ESF0 is doing worse than 66.67% of the companies in the same industry.
  • ESF0's Operating Margin has declined in the last couple of years.
  • ESF0's Gross Margin of 21.39% is on the low side compared to the rest of the industry. ESF0 is outperformed by 77.78% of its industry peers.
  • In the last couple of years the Gross Margin of ESF0 has declined.
Industry RankSector Rank
OM 10.87%
PM (TTM) 5.62%
GM 21.4%
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
ESF0.DE Yearly Profit, Operating, Gross MarginsESF0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

5

2. ESF0.DE Health Analysis

2.1 Basic Checks

  • ESF0 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ESF0 has less shares outstanding
  • Compared to 5 years ago, ESF0 has less shares outstanding
  • Compared to 1 year ago, ESF0 has a worse debt to assets ratio.
ESF0.DE Yearly Shares OutstandingESF0.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ESF0.DE Yearly Total Debt VS Total AssetsESF0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.49 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ESF0 has a Altman-Z score (2.49) which is in line with its industry peers.
  • ESF0 has a debt to FCF ratio of 5.14. This is a neutral value as ESF0 would need 5.14 years to pay back of all of its debts.
  • ESF0 has a Debt to FCF ratio of 5.14. This is in the better half of the industry: ESF0 outperforms 77.78% of its industry peers.
  • A Debt/Equity ratio of 0.82 indicates that ESF0 is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ESF0 (0.82) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Altman-Z 2.49
ROIC/WACC0.87
WACC7.77%
ESF0.DE Yearly LT Debt VS Equity VS FCFESF0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • ESF0 has a Current Ratio of 1.09. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ESF0 (1.09) is comparable to the rest of the industry.
  • ESF0 has a Quick Ratio of 1.03. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, ESF0 is in line with its industry, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.03
ESF0.DE Yearly Current Assets VS Current LiabilitesESF0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

5

3. ESF0.DE Growth Analysis

3.1 Past

  • ESF0 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.73%, which is quite good.
  • Measured over the past years, ESF0 shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.09% on average per year.
  • The Revenue has been growing slightly by 4.96% in the past year.
  • The Revenue has been growing slightly by 6.05% on average over the past years.
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%

3.2 Future

  • ESF0 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.11% yearly.
  • Based on estimates for the next years, ESF0 will show a small growth in Revenue. The Revenue will grow by 7.47% on average per year.
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue Next Year4.69%
Revenue Next 2Y5.62%
Revenue Next 3Y5.95%
Revenue Next 5Y7.47%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ESF0.DE Yearly Revenue VS EstimatesESF0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ESF0.DE Yearly EPS VS EstimatesESF0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

5

4. ESF0.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • ESF0 is valuated correctly with a Price/Earnings ratio of 16.59.
  • Based on the Price/Earnings ratio, ESF0 is valued a bit cheaper than 72.22% of the companies in the same industry.
  • ESF0 is valuated rather cheaply when we compare the Price/Earnings ratio to 24.75, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 15.81 indicates a correct valuation of ESF0.
  • Based on the Price/Forward Earnings ratio, ESF0 is valued a bit cheaper than the industry average as 72.22% of the companies are valued more expensively.
  • ESF0 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.59
Fwd PE 15.81
ESF0.DE Price Earnings VS Forward Price EarningsESF0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ESF0 is valued cheaper than 83.33% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ESF0 is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.03
EV/EBITDA 9.81
ESF0.DE Per share dataESF0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ESF0 does not grow enough to justify the current Price/Earnings ratio.
  • ESF0's earnings are expected to grow with 13.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.99
PEG (5Y)N/A
EPS Next 2Y11.81%
EPS Next 3Y13.96%

6

5. ESF0.DE Dividend Analysis

5.1 Amount

  • ESF0 has a Yearly Dividend Yield of 1.17%.
  • ESF0's Dividend Yield is rather good when compared to the industry average which is at 0.52. ESF0 pays more dividend than 83.33% of the companies in the same industry.
  • ESF0's Dividend Yield is slightly below the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.17%

5.2 History

  • The dividend of ESF0 is nicely growing with an annual growth rate of 16.09%!
Dividend Growth(5Y)16.09%
Div Incr Years1
Div Non Decr Years1
ESF0.DE Yearly Dividends per shareESF0.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • ESF0 pays out 26.80% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of ESF0 is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP26.8%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
ESF0.DE Yearly Income VS Free CF VS DividendESF0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ESF0.DE Dividend Payout.ESF0.DE Dividend Payout, showing the Payout Ratio.ESF0.DE Dividend Payout.PayoutRetained Earnings

ESF0.DE Fundamentals: All Metrics, Ratios and Statistics

EUROFINS SCIENTIFIC

FRA:ESF0 (3/26/2026, 7:00:00 PM)

61.7

+0.6 (+0.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners33.9%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap11.24B
Revenue(TTM)7.30B
Net Income(TTM)409.70M
Analysts72
Price Target72.63 (17.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.17%
Yearly Dividend0.6
Dividend Growth(5Y)16.09%
DP26.8%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.21%
PT rev (3m)9.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.42%
EPS NY rev (3m)-2%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE 16.59
Fwd PE 15.81
P/S 1.54
P/FCF 13.03
P/OCF 8.03
P/B 2.47
P/tB N/A
EV/EBITDA 9.81
EPS(TTM)3.72
EY6.03%
EPS(NY)3.9
Fwd EY6.32%
FCF(TTM)4.73
FCFY7.67%
OCF(TTM)7.68
OCFY12.45%
SpS40.05
BVpS24.94
TBVpS-4.41
PEG (NY)1.99
PEG (5Y)N/A
Graham Number45.69
Profitability
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROCE 9.27%
ROIC 6.74%
ROICexc 7.43%
ROICexgc 23.86%
OM 10.87%
PM (TTM) 5.62%
GM 21.4%
FCFM 11.82%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
ROICexc(3y)7.17%
ROICexc(5y)9.25%
ROICexgc(3y)23.01%
ROICexgc(5y)30.49%
ROCE(3y)8.97%
ROCE(5y)11.81%
ROICexgc growth 3Y-10.94%
ROICexgc growth 5Y-13.82%
ROICexc growth 3Y-8.95%
ROICexc growth 5Y-10.36%
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Debt/EBITDA 2.44
Cap/Depr 74.23%
Cap/Sales 7.35%
Interest Coverage 6.87
Cash Conversion 92.26%
Profit Quality 210.5%
Current Ratio 1.09
Quick Ratio 1.03
Altman-Z 2.49
F-Score7
WACC7.77%
ROIC/WACC0.87
Cap/Depr(3y)77.81%
Cap/Depr(5y)87.04%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.15%
Profit Quality(3y)205.64%
Profit Quality(5y)166.63%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
Revenue Next Year4.69%
Revenue Next 2Y5.62%
Revenue Next 3Y5.95%
Revenue Next 5Y7.47%
EBIT growth 1Y-4.65%
EBIT growth 3Y-8.54%
EBIT growth 5Y-4.97%
EBIT Next Year81.37%
EBIT Next 3Y28.68%
EBIT Next 5Y24.78%
FCF growth 1Y9.1%
FCF growth 3Y21.91%
FCF growth 5Y-0.13%
OCF growth 1Y6.07%
OCF growth 3Y7.18%
OCF growth 5Y2.72%

EUROFINS SCIENTIFIC / ESF0.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ESF0.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ESF0.DE.


What is the valuation status for ESF0 stock?

ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Fairly Valued.


What is the profitability of ESF0 stock?

EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ESF0.DE) is 16.59 and the Price/Book (PB) ratio is 2.47.


How sustainable is the dividend of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 6 / 10 and the dividend payout ratio is 26.8%.